Chief Financial Officer
Keith Goldan has served as our Chief Financial Officer since June 2022.
Keith served as Chief Financial Officer of Optinose, a publicly traded specialty pharmaceutical company, since January 2017, where he helped build the infrastructure to support the launch of its lead product in the United States. Prior to Optinose, he served as Chief Financial Officer and Senior Vice President of Fibrocell, a publicly traded cell and gene therapy company. Keith’s experience also includes Chief Financial Officer roles at NuPathe, PuriCore plc and Biosyn, as well as financial roles at ViroPharma and KPMG. In these positions, Keith led finance, accounting, IT, HR and corporate development teams and successfully raised capital through multiple IPOs, capital markets transactions and financing vehicles.
Keith received a B.S. in Finance from the Robert H. Smith School of Business at the University of Maryland and an M.B.A. from the Wharton School at the University of Pennsylvania.